Page last updated: 2024-09-03

ginsenoside rh2 and pyronine

ginsenoside rh2 has been researched along with pyronine in 1 studies

Compound Research Comparison

Studies
(ginsenoside rh2)
Trials
(ginsenoside rh2)
Recent Studies (post-2010)
(ginsenoside rh2)
Studies
(pyronine)
Trials
(pyronine)
Recent Studies (post-2010) (pyronine)
2951200266053

Protein Interaction Comparison

ProteinTaxonomyginsenoside rh2 (IC50)pyronine (IC50)
Apoptotic peptidase activating factor 1Homo sapiens (human)42
nonstructural protein 1Influenza A virus (A/California/07/2009(H1N1))26.873
caspase-9 isoform alpha precursorHomo sapiens (human)16.8
caspase-3 isoform a preproproteinHomo sapiens (human)16.8

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Q; He, J; Liu, J; Lu, M; Sun, X; Sun, Y; Wang, G; Wang, Y; Zhang, J; Zhang, X; Zhou, F1

Other Studies

1 other study(ies) available for ginsenoside rh2 and pyronine

ArticleYear
Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.
    European journal of pharmacology, 2014, Oct-05, Volume: 740

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Synergism; Ginsenosides; Male; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Peritonitis; Protein Conformation; Pyronine; RNA, Messenger; Staphylococcal Infections; Staphylococcus aureus

2014